<DOC>
	<DOCNO>NCT03045822</DOCNO>
	<brief_summary>There increase number patient cardiac implantable electronic device ( CIEDs ) pacemaker ( PM ) implantable cardioverter-defibrillators ( ICDs ) worldwide . The current medical practice guideline warn perform bioimpedance analysis ( BIA ) group patient avoid electromagnetic interference . These recommendation restrict use BIA many patient heart failure BIA might great interest detect peripheral congestion guidance treatment . However , well know whether BIA affect function cardiac device . Investigators aim test incidence electromagnetic interference BIA CIEDs .</brief_summary>
	<brief_title>BIA Cardiac Implantable Electronic Devices</brief_title>
	<detailed_description>Patients enrollment routine face-to-face consultation , schedule PM ICDs interrogation . Investigators record BIA measure , battery voltage device , lead impedance stimulation threshold . The device electrograms monitor BIA measurement detect electromagnetic interference oversensing .</detailed_description>
	<criteria>Patient cardiac device without cardiac resynchronization 18 year age Patients pacingdependent status Patients read , understood sign write informed consent letter Patients acute heart failure Patients implant less 2 month Dysfunction device followup visit inclusion visit Patients particular device lead model prone develop electronical problem Sprint Fidelis Medtronic ( Minneapolis , USA ) Riata St. Jude Medical ( St. Paul , USA ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Bioimpedance analysis</keyword>
	<keyword>implantable cardioverter-defibrillators</keyword>
	<keyword>pacemaker</keyword>
</DOC>